<DOC>
	<DOCNO>NCT00704275</DOCNO>
	<brief_summary>To compare efficacy , safety tolerability 0.05 % topical cyclosporin eye drop Refresh moderate severe dry eye patient . Null hypothesis : difference two group .</brief_summary>
	<brief_title>Comparison Efficacy , Safety Anti-Inflammatory Effect Between Topical 0.05 % Cyclosporine A Emulsion REFRESHÂ® Patients With Moderate Severe Dry Eyes</brief_title>
	<detailed_description>Inclusion criterion : 1 . Participants moderate severe dry eye patient age 18 year age 2 . Oxford stain score five . 3 . OSDI score 0.1 Outcome measurement : Main parameter stain score ( corneal + conjunctival ) Other parameter OSDI score , symptom ocular surface discomfort score , number daily artificial tear need , TBUT , Schirmer I score , cytokine level &amp; marker Safety parameter : VA , IOP , cyclosporin level</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>moderate severe dry eye lid anomaly , previous CsA use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>dry eye</keyword>
</DOC>